Maxillary giant cell reparative granuloma

Area of Science:

• Oral and Maxillofacial Surgery
• Pathology
• Radiology

Background:

• Giant cell reparative granuloma (GCRG) was first described in 1953, initially considered a variant of giant cell tumors or osteitis fibrosa.
• Distinguishing GCRG from central giant cell tumors of bone is crucial, though most evidence suggests true giant cell tumors rarely occur in jaws.
• Histologically, GCRGs share features with other giant cell lesions, including peripheral and central intraosseous lesions and cherubism.

Observation:

• GCRGs present as localized maxillary swelling, often smooth and rubbery on palpation due to thinned bone.
• Radiographic signs are non-specific, necessitating a comprehensive diagnostic approach.
• Diagnosis requires integrating physical examination, patient history, laboratory results, radiographic findings, and clinical follow-up.

Findings:

• GCRGs are characterized histologically as proliferative fibroblastic lesions containing multinucleated giant cells.
• The histopathology of GCRGs in jaw bones appears identical to that of giant cell tumors in long bones.
• Conservative surgical management is the established and effective treatment for GCRGs.

Implications:

• Accurate diagnosis of GCRG is essential for appropriate management, differentiating it from other giant cell lesions.
• Conservative surgical excision is the preferred treatment, avoiding risks associated with radiation therapy.
• Further research may clarify the precise etiology and pathogenesis of GCRGs, optimizing diagnostic and therapeutic strategies.